Irfan Agha

1.2k total citations · 1 hit paper
18 papers, 891 citations indexed

About

Irfan Agha is a scholar working on Nephrology, Oncology and Transplantation. According to data from OpenAlex, Irfan Agha has authored 18 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 5 papers in Oncology and 4 papers in Transplantation. Recurrent topics in Irfan Agha's work include Renal Diseases and Glomerulopathies (5 papers), Polyomavirus and related diseases (5 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Irfan Agha is often cited by papers focused on Renal Diseases and Glomerulopathies (5 papers), Polyomavirus and related diseases (5 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Irfan Agha collaborates with scholars based in United States, United Kingdom and Pakistan. Irfan Agha's co-authors include Daniel C. Brennan, Monique Gaudreault‐Keener, Gregory A. Storch, Mark A. Schnitzler, Karen L. Hardinger, Daniel L. Bohl, Mark B. Lockwood, Christine M. Durand, Brent W. Miller and Gary G. Singer and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and American Journal of Kidney Diseases.

In The Last Decade

Irfan Agha

14 papers receiving 875 citations

Hit Papers

Incidence of BK with Tacrolimus Versus Cyclosporine and I... 2005 2026 2012 2019 2005 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irfan Agha United States 8 612 395 228 179 164 18 891
Brahm Vasudev United States 10 430 0.7× 222 0.6× 161 0.7× 96 0.5× 114 0.7× 12 658
J Trofe United States 15 539 0.9× 209 0.5× 126 0.6× 154 0.9× 120 0.7× 40 824
Nobuyuki Goya Japan 12 167 0.3× 258 0.7× 72 0.3× 215 1.2× 55 0.3× 52 609
Olivier D. Prince Switzerland 6 690 1.1× 183 0.5× 282 1.2× 31 0.2× 219 1.3× 6 844
Caroline Wehmeier Switzerland 13 110 0.2× 349 0.9× 42 0.2× 175 1.0× 40 0.2× 31 455
Gantuja Bold Germany 7 125 0.2× 239 0.6× 52 0.2× 138 0.8× 26 0.2× 8 437
Tarek Said Kuwait 13 93 0.2× 106 0.3× 79 0.3× 63 0.4× 18 0.1× 60 448
A. Benedict Cosimi United States 8 102 0.2× 106 0.3× 44 0.2× 113 0.6× 21 0.1× 11 420
K.A.M.I. van Donselaar–van der Pant Netherlands 11 59 0.1× 137 0.3× 78 0.3× 66 0.4× 8 0.0× 18 379
M. Harler United States 5 74 0.1× 454 1.1× 62 0.3× 253 1.4× 6 0.0× 13 610

Countries citing papers authored by Irfan Agha

Since Specialization
Citations

This map shows the geographic impact of Irfan Agha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irfan Agha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irfan Agha more than expected).

Fields of papers citing papers by Irfan Agha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irfan Agha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irfan Agha. The network helps show where Irfan Agha may publish in the future.

Co-authorship network of co-authors of Irfan Agha

This figure shows the co-authorship network connecting the top 25 collaborators of Irfan Agha. A scholar is included among the top collaborators of Irfan Agha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irfan Agha. Irfan Agha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kooienga, Laura, Eun Young Lee, Sung Gyun Kim, et al.. (2025). Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathy. Kidney International. 108(3). 445–454. 1 indexed citations
2.
Barratt, Jonathan, Laura Kooienga, Irfan Agha, et al.. (2023). #4337 UPDATED INTERIM RESULTS OF A PHASE 1/2 STUDY OF BION-1301 IN PATIENTS WITH IGA NEPHROPATHY. Nephrology Dialysis Transplantation. 38(Supplement_1). 3 indexed citations
3.
Barratt, Jonathan, Laura Kooienga, Irfan Agha, et al.. (2022). Updated Interim Results of a Phase 1/2 Study of BION-1301 in Patients With IgA Nephropathy. Journal of the American Society of Nephrology. 33(11S). 503–503. 2 indexed citations
4.
Barratt, Jonathan, Laura Kooienga, Irfan Agha, et al.. (2022). MO212: Updated Interim Results of A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Activity of BION-1301 in Patients With IGA Nephropathy. Nephrology Dialysis Transplantation. 37(Supplement_3). 5 indexed citations
5.
Agha, Irfan, et al.. (2021). Large Abdominal Mass: An Unusual Presentation of Multiple Myeloma. Journal of the American Society of Nephrology. 32(10S). 583–583.
6.
Agha, Irfan, et al.. (2021). Snow White and the Apple: When Drugs Become Poisons. Journal of the American Society of Nephrology. 32(10S). 624–624.
7.
Agha, Irfan, et al.. (2020). Living Donor-Derived APOL1-Associated Collapsing FSGS in a Kidney Transplant Recipient. Journal of the American Society of Nephrology. 31(10S). 776–777.
8.
Stites, Erik, Dhiren Kumar, S. John Swanson, et al.. (2020). High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury. American Journal of Transplantation. 20(9). 2491–2498. 99 indexed citations
9.
Agha, Irfan, et al.. (2020). Current State and Future of Private Practice Nephrology in the United States. Advances in Chronic Kidney Disease. 27(4). 356–360.e1.
10.
Durand, Christine M., et al.. (2016). Epstein–Barr virus and renal transplantation. Transplantation Reviews. 31(1). 55–60. 40 indexed citations
11.
Ortíz, Jorge, Francis H. Wright, Adam W. Bingaman, et al.. (2008). Campath Induction for Kidney Transplantation: Report of 297 Cases. Transplantation. 85(11). 1550–1556. 31 indexed citations
12.
Agha, Irfan & Daniel C. Brennan. (2006). BK Virus and Immunosuppressive Agents. Advances in experimental medicine and biology. 577. 174–184. 20 indexed citations
13.
Brennan, Daniel C., Irfan Agha, Daniel L. Bohl, et al.. (2005). Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction. American Journal of Transplantation. 5(3). 582–594. 540 indexed citations breakdown →
14.
Bohl, Delphine, et al.. (2004). HIGH DONOR ANTIBODY LEVEL AND HLA C7 PREDICT SUSTAINED BK-POLYOMA VIREMIA: RESULTS OF A RANDOMIZED PROSPECTIVE TRIAL. Transplantation. 78. 488–488. 2 indexed citations
15.
Agha, Irfan, Jose Rueda, Gary G. Singer, et al.. (2002). SHORT COURSE INDUCTION IMMUNOSUPPRESSION WITH THYMOGLOBULIN FOR RENAL TRANSPLANT RECIPIENTS1. Transplantation. 73(3). 473–475. 107 indexed citations
16.
Agha, Irfan, et al.. (2002). Systemic amyloidosis associated with pleomorphic sarcoma of the spleen and remission of nephrotic syndrome after removal of the tumor. American Journal of Kidney Diseases. 40(2). 411–415. 13 indexed citations
17.
Agha, Irfan & Daniel C. Brennan. (2002). BK Virus and Current Immunosuppressive Therapy. 5. S65–S72. 23 indexed citations
18.
Salahuddin, Naseem, et al.. (1993). Enoxacin in the treatment of typhoid fever.. PubMed. 14(6). 825–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026